ERBB2 and melanoma: Both Con-IgE and Neu-IgE recognized and bound the target antigen CSPG4-expressing A2058 human melanoma cells in a similar dose-dependent manner [Figure 4C], suggesting that sialic acid reduction had no obvious impact on the Fab-mediated binding of IgE on target antigen-expressing cancer cells.